据增长报告,损失、收入下降较窄,但与药物性大麻增长相比,这一数字高于估计数。 Canopy Growth reports narrower loss, revenue dip, but beats estimates with medical cannabis growth.

加拿大大麻公司Canopy增长公司报告说,第三季度损失较窄,为1.219亿美元,低于一年前的2.168亿美元。 Canadian cannabis firm Canopy Growth Corp. reported a narrower third-quarter loss of $121.9 million, down from $216.8 million a year ago. 净收入从7 850万美元下降到7 480万美元,但由于医用大麻、蒸发剂和国际销售的增长,收入上升了8%,不包括已出售的企业。 Net revenue fell to $74.8 million from $78.5 million, but rose 8% excluding sold businesses, due to growth in medical cannabis, vaporizers, and international sales. 尽管债务下降,但公司债务减少,收入估计业绩超过预期。 Despite the decline, the company saw a reduction in debt and outperformed revenue estimates.